What causes elevated parathyroid hormone with low calcium and how should it be evaluated and managed?

Elevated Parathyroid Hormone with Low Calcium: Secondary Hyperparathyroidism

When PTH is elevated in the setting of hypocalcemia, this represents secondary hyperparathyroidism—a physiological response to low calcium rather than a primary parathyroid disorder—and the priority is to identify and correct the underlying cause driving the calcium deficiency. 1, 2

Diagnostic Approach

Initial Laboratory Evaluation

Measure the following simultaneously to establish the diagnosis and identify the etiology:

• Serum ionized or albumin-corrected calcium (confirms hypocalcemia) 3, 4
• Intact PTH (elevated or inappropriately normal in secondary hyperparathyroidism) 1, 2
• Serum phosphate (helps differentiate causes; elevated in hypoparathyroidism, variable in secondary hyperparathyroidism) 1, 3
• Serum magnesium (hypomagnesemia impairs PTH secretion and action, mimicking hypoparathyroidism) 1, 3
• 25-hydroxyvitamin D (deficiency is the most common cause of secondary hyperparathyroidism) 2, 5, 4
• Serum creatinine/eGFR (chronic kidney disease causes secondary hyperparathyroidism through phosphate retention and impaired vitamin D activation) 6, 7
• Fractional excretion of calcium (FeCa) if considering familial hypocalciuric hypercalcemia in the differential 2

Key Diagnostic Patterns

The biochemical signature differs from primary hyperparathyroidism:

• Low or low-normal calcium with elevated PTH indicates secondary hyperparathyroidism 2, 8
• Normal or elevated phosphate (versus low phosphate in primary hyperparathyroidism) 1, 8
• Low urinary calcium excretion (FeCa typically <2%) 2

Common Etiologies to Evaluate

Vitamin D Deficiency

This is the most frequent cause of secondary hyperparathyroidism in patients with normal renal function. 5, 8

• Confirm with 25-hydroxyvitamin D <20 ng/mL (50 nmol/L) 5, 4
• Consider malabsorption syndromes (celiac disease, inflammatory bowel disease, post-bariatric surgery) if dietary intake appears adequate 8, 9
• Assess for medications that accelerate vitamin D metabolism (anticonvulsants, rifampin) 8

Inadequate Calcium Intake

Secondary hyperparathyroidism can result from insufficient dietary calcium even when vitamin D levels are normal. 10

• Obtain detailed dietary history; typical inadequate intake is <400-600 mg/day 10, 11
• A calcium challenge test (oral calcium 600 mg twice daily for 2-3 weeks) can confirm this diagnosis: PTH normalizes if insufficient intake was the cause 10
• This is particularly common in elderly patients and those avoiding dairy products 10, 11

Chronic Kidney Disease

CKD causes secondary hyperparathyroidism through multiple mechanisms: phosphate retention, impaired 1α-hydroxylation of vitamin D, and skeletal resistance to PTH. 6, 7

• Suspect when eGFR <45 mL/min/1.73 m² (CKD stages G3b-G5) 6, 7
• Measure calcium, phosphate, PTH, and alkaline phosphatase at baseline in all patients with eGFR <45 7
• The optimal PTH level in CKD is unknown; evaluate for hyperphosphatemia, hypocalcemia, and vitamin D deficiency before attributing elevated PTH to CKD-mineral bone disorder 6, 7

Magnesium Disorders

Severe hypomagnesemia (<1.0 mg/dL) impairs both PTH secretion and end-organ responsiveness, causing functional hypoparathyroidism with low calcium and inappropriately low or normal PTH. 1, 3

• Check magnesium in every hypocalcemic patient 3, 4
• Calcium repletion is ineffective until magnesium is corrected 3, 4
• Consider causes: diuretics, proton pump inhibitors, alcohol use, gastrointestinal losses, genetic disorders 1

Postsurgical Hypoparathyroidism

If there is recent anterior neck surgery (thyroidectomy, parathyroidectomy):

• Measure PTH 12-24 hours post-thyroidectomy; if PTH >10 pg/mL (1.05 pmol/L), permanent hypoparathyroidism is unlikely 3
• Chronic hypoparathyroidism is confirmed ≥12 months after surgery with persistent hypocalcemia and inappropriately low or normal PTH on two occasions at least 2 weeks apart 3
• Distinguish from "hungry bone syndrome" (rapid bone remineralization causing transient severe hypocalcemia despite normal/elevated PTH) 4, 12

Management Strategy

Correct Magnesium First

Before treating hypocalcemia, normalize serum magnesium with intravenous magnesium sulfate or oral supplementation. 3, 4

Vitamin D Deficiency

• Supplement with cholecalciferol or ergocalciferol to achieve 25-hydroxyvitamin D >20 ng/mL (50 nmol/L) 5, 4, 12
• Typical dosing: 1,000-4,000 IU daily, higher doses (up to 50,000 IU weekly) for severe deficiency 6, 5
• Ensure adequate dietary calcium intake (1,000-1,200 mg/day) 5, 10

Inadequate Calcium Intake

• Initiate oral elemental calcium 1,000-1,500 mg daily in divided doses 3, 10
• Calcium carbonate (40% elemental calcium) taken with meals for optimal absorption 3
• Calcium citrate preferred if taking proton pump inhibitors or with achlorhydria 3
• Recheck PTH after 2-3 weeks; normalization confirms the diagnosis 10

CKD-Related Secondary Hyperparathyroidism

• Maintain serum phosphate in the normal range through dietary restriction (<800-1,000 mg/day) and phosphate binders 6, 7
• Calcium-based binders preferred over aluminum-based agents 12
• Supplement native vitamin D (cholecalciferol) if 25-hydroxyvitamin D <30 ng/mL 6, 12
• Active vitamin D analogues (calcitriol, alfacalcidol) are NOT routinely recommended for PTH suppression in CKD patients not on dialysis in the absence of documented deficiency 6, 7
• Target intact PTH 150-300 pg/mL in dialysis patients 12

Chronic Hypoparathyroidism (Postsurgical or Idiopathic)

• Oral elemental calcium 1-3 g daily in divided doses 3, 4
• Add active vitamin D: calcitriol 0.25-0.75 µg daily or alfacalcidol 0.5-1.5 µg daily 3, 4, 12
• Target serum calcium in the low-normal range (8.0-8.5 mg/dL) to minimize hypercalciuria and risk of nephrocalcinosis 3, 4
• Monitor 24-hour urinary calcium; if >300 mg/day, reduce calcium and active vitamin D doses 3

Monitoring Protocol

Short-Term (First 1-3 Months)

• Measure serum calcium and phosphate every 2 weeks when initiating or escalating therapy 12
• Check PTH monthly for the first 3 months 12
• Obtain 24-hour urine calcium after 1 month of stable dosing in chronic hypoparathyroidism 3

Long-Term

• Serum calcium, phosphate, and magnesium every 3-6 months 3, 12
• PTH every 3-6 months once stable 3, 12
• Annual 24-hour urine calcium, creatinine, and renal imaging (ultrasound) to screen for nephrocalcinosis and kidney stones 3
• Baseline and periodic renal function (eGFR) 3
• Consider bone density (DXA) at baseline and every 1-2 years in chronic hypoparathyroidism 3

Critical Pitfalls to Avoid

• Do not overlook hypomagnesemia—calcium repletion fails without correcting magnesium deficiency first 3, 4
• Do not diagnose primary hyperparathyroidism when calcium is low or low-normal; elevated PTH with hypocalcemia is secondary hyperparathyroidism until proven otherwise 2
• Do not use cinacalcet in hypocalcemic patients—it worsens hypocalcemia and prolongs QT interval 4, 12
• Do not over-correct calcium in chronic hypoparathyroidism; target low-normal range to prevent hypercalciuria, nephrocalcinosis, and renal failure 3, 4
• Do not prescribe active vitamin D (calcitriol) for PTH suppression in CKD patients without documented vitamin D deficiency—evidence of benefit is lacking 6, 7
• Do not assume vitamin D deficiency is the sole cause; always measure magnesium, assess calcium intake, and evaluate renal function 2, 3, 10
• Stop biotin supplements (if >5 mg daily) at least 3 days before PTH testing to avoid falsely low results from assay interference 3